These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 3049560

  • 1. Clinical outcome and adverse effect profile associated with concurrent administration of alprazolam and imipramine.
    Wells BG, Evans RL, Ereshefsky L, Antal EJ, Lobeck F, Rawls WN, Hamann G, Grimmig J, Smith RB.
    J Clin Psychiatry; 1988 Oct; 49(10):394-9. PubMed ID: 3049560
    [Abstract] [Full Text] [Related]

  • 2. A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly.
    Weissman MM, Prusoff B, Sholomskas AJ, Greenwald S.
    J Clin Psychopharmacol; 1992 Jun; 12(3):175-82. PubMed ID: 1629383
    [Abstract] [Full Text] [Related]

  • 3. Comparison of alprazolam and imipramine for treatment of outpatient depression.
    Overall JE, Biggs J, Jacobs M, Holden K.
    J Clin Psychiatry; 1987 Jan; 48(1):15-9. PubMed ID: 3542981
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
    Hoehn-Saric R, McLeod DR, Zimmerli WD.
    J Clin Psychiatry; 1988 Aug; 49(8):293-301. PubMed ID: 3045099
    [Abstract] [Full Text] [Related]

  • 5. Effect size as a measure of symptom-specific drug change in clinical trials.
    Leon AC, Shear MK, Portera L, Klerman GL.
    Psychopharmacol Bull; 1993 Aug; 29(2):163-7. PubMed ID: 8290660
    [Abstract] [Full Text] [Related]

  • 6. Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients.
    Mendels J, Schless AP.
    J Clin Psychiatry; 1986 Jul; 47(7):357-61. PubMed ID: 2873131
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
    León CA, De Arango MV, Arevalo W, Calvo A, Montoya A, León A.
    Acta Psiquiatr Psicol Am Lat; 1990 Jul; 36(1-2):59-72. PubMed ID: 2073024
    [Abstract] [Full Text] [Related]

  • 8. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients.
    Fawcett J, Edwards JH, Kravitz HM, Jeffriess H.
    J Clin Psychopharmacol; 1987 Oct; 7(5):295-310. PubMed ID: 3316312
    [Abstract] [Full Text] [Related]

  • 9. Adequate treatment with imipramine in continuation treatment.
    Kupfer DJ, Perel JM, Frank E.
    J Clin Psychiatry; 1989 Jul; 50(7):250-5. PubMed ID: 2661546
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK, van den Broek WW, Mulder PG, Moleman P, Bruijn JA.
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [Abstract] [Full Text] [Related]

  • 11. Implications of restrictive diagnosis for compliance to antidepressant drug therapy: alprazolam versus imipramine.
    Overall JE, Donachie ND, Faillace LA.
    J Clin Psychiatry; 1987 Feb; 48(2):51-4. PubMed ID: 3542984
    [Abstract] [Full Text] [Related]

  • 12. [Randomized double-blind comparative study of the efficacy and tolerance of medifoxamine and imipramine in depressed patients].
    Olié JP, Galinowski A, Lehert P, Lemonnier F, Lôo H.
    Encephale; 1993 Feb; 19(4):333-40. PubMed ID: 8275921
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Alprazolam in the treatment of anxiety disorders and mixed anxiety and depressive disorders. Results of multicenter clinical trial].
    Kiejna A, Małyszczak K, Rzewuska M, Sobucka K, Florkowski A, Rajewski A, Rajewska J, Wojtanowska M, Dabkowski M, Brzeziński R, Rybakowski J, Sep-Kowalikowa B, Gałuszko P, Nowicki Z.
    Psychiatr Pol; 1996 Feb; 30(6):973-92. PubMed ID: 9132771
    [Abstract] [Full Text] [Related]

  • 16. Multicenter double-blind comparison of nomifensine and imipramine for efficacy and safety in depressed outpatients.
    Bremner JD, Abrahams LM, Crupie JE, McCawley A, Proctor RC, Sathananthan GL.
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):56-9. PubMed ID: 6370976
    [Abstract] [Full Text] [Related]

  • 17. Comparative studies of pharmacotherapy for school refusal.
    Bernstein GA, Garfinkel BD, Borchardt CM.
    J Am Acad Child Adolesc Psychiatry; 1990 Sep; 29(5):773-81. PubMed ID: 2228932
    [Abstract] [Full Text] [Related]

  • 18. Nomifensine vs. imipramine in depressed inpatients.
    Fann WE, Lyle FA, Higginbotham W.
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):60-2. PubMed ID: 6370978
    [Abstract] [Full Text] [Related]

  • 19. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM, Mallinckrodt CH, Prakash A, Watkin JG, Carter WP.
    Depress Anxiety; 2007 Apr; 24(1):41-52. PubMed ID: 16845641
    [Abstract] [Full Text] [Related]

  • 20. Imipramine blood levels and clinical outcome.
    Rigal JG, Albin HC, Duchier AR, D'Aulnay JM, Fenelon JH, Vincon GA, Demotes-Mainard FM.
    J Clin Psychopharmacol; 1987 Aug; 7(4):222-9. PubMed ID: 3624505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.